The Silent Epidemic of Adverse Drug Reactions in Africa
A new analysis in Clinical Pharmacology & Therapeutics investigates the burden of adverse drug reactions (ADRs) across the African continent, a region with vast genetic diversity but limited pharmacogenetic testing. The study, which inferred the role of genetic variation from international pharmacogenomics guidelines, found that African countries report only 1% of ADRs in the global VigiBase database, highlighting a critical weakness in pharmacovigilance systems.
Continue reading to unlock the full analysis, deeper implications, and why this study may matter for your field.
Unlock Full Briefing — 50% Off with Coupon: ERWMCWYU
Full version includes the complete summary, study significance, and direct link to the original source.
Stay curious. Stay informed — with Science Briefing.
This is a preview briefing. Upgrade to access the full version.
